Atlas Trials

Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients

Clinical trial NCT04737187 · COMPLETED

Trial details

NCT number
NCT04737187
Sponsor
Taiho Oncology, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Refractory Metastatic Colorectal Cancer
Start date
2020-11-25
Primary completion
2022-07-19
Enrollment
492

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.